Skip to main content
. 2005 Jan 12;102(3):719–724. doi: 10.1073/pnas.0408894102

Table 1. All prostate cancer-associated COI mutations.

Mutant Amino acid Cl Haplogroup Prostate Blood Case
C59111 A3V 13 U M M 18
G5913A D4N 18 K M M 8
A5935G N11S 100 N M M* 29
G5949A G16X U M/W W 18
G5973A A24T 92 H M M 3
G6081A A60T 97 L2 M M 31
G6150A V83I 95 L1 M M 21
T6124C M74T 95 T M/W M/W 19
T6253C M117T 69 H M M 1, 2, 4
G6261A A120T 97 J, T, L1, N M M 6, 7, 17, 26, 27, 30
G6267A A122T 92 L1 M M 24
G6285A V128I 100 H M M 16
C6340T T146I 79 H, N M M* 5, 23
G6480A V193I 87 I M M 14
A6663G I254V 95 O, L2 M M 12, 13, 20, 22, 25
G6924T A341S 100 K M W
G7041A V380I 100 T M M 9
T7080C F393L 97 U M M* 10
A7083G I395V 33 H M M 15
A7158G I419V 21 N M M* 28
A7305C M468L 90 U M M 11

M, mutant; W, wild type.

*

Four cases had no blood available. DNA sequencing of a separate organ (seminal vesicle) in these four cases confirmed these as germ-line mutations. Variants 7389 and 7146, defining L0 and L0L1, respectively, were not considered